PARACETAMOL DAN DIFENHIDRAMIN SEBAGAI MEDIKASI PRETRANFUSI KEJADIAN FEBRILE NON-HAEMOLYTIC REACTION TRANSFUSION RESIPIEN TROMBOSIT

Background. Blood transfusion can save lives, patients get the benefit but also the risk of transfusion-related. Febrile non-haemolytic tranfusion reaction (FNHTR) most frequently found and have similar symptoms of other transfusion reactions, causing delays in transfusion and decrease the quality o...

Full description

Bibliographic Details
Main Authors: , Pudya Lestari Arhsanti, , dr. Johan Kurnianda,. Sp. PD.KHOM.
Format: Thesis
Published: [Yogyakarta] : Universitas Gadjah Mada 2011
Subjects:
ETD
_version_ 1826033603262283776
author , Pudya Lestari Arhsanti
, dr. Johan Kurnianda,. Sp. PD.KHOM.
author_facet , Pudya Lestari Arhsanti
, dr. Johan Kurnianda,. Sp. PD.KHOM.
author_sort , Pudya Lestari Arhsanti
collection UGM
description Background. Blood transfusion can save lives, patients get the benefit but also the risk of transfusion-related. Febrile non-haemolytic tranfusion reaction (FNHTR) most frequently found and have similar symptoms of other transfusion reactions, causing delays in transfusion and decrease the quality of life. Platelet recipients have a higher incidence risk FNHTR than recipients of other blood products. Medications pretransfusion acetaminophen and diphenhydramine reduce the incidence FNHTR. Methods. The study was conducted from May to November 2010 Penyakit Dalam Wards, Dr. Sardjito Hospital, Yogyakarta using the method of double-blind randomized controlled trial. Inclusion criteria were first recipient of random donor non leucodepleted platelets in thrombocytopenia malignant patients and willing to participate. Exclusion criteria were fever is when will transfusions or in 2x24 hours, allergies of acetaminophen and diphenhydramine, acetaminophen and diphenhydramine consumption in the last 6 hours, the consumption of continuous corticosteroids, history of transfusion reactions and critical conditions/sepsis. Assessment of the incidence FNHTR than 15 minutes before transfusion to 4 hours after transfusion. Medication group will receive a capsule containing 650 mg acetaminophen and 25 mg diphenhydramine dissolved in 5 ml 0.9% NaCl intravenously. The control group received a placebo. Drugs are given 30 minutes before the first transfusion bag. Data were analyzed using Chi-square test and p <0.05 was considered statistically significant. Results. Thirty-two patients met the criteria, 15 patients (46.87%), medication group and 17 (53.13%) patients of control group. Eleven (31.43%) patients had FNHTR, 8 (47.06%) patients of control group and 3 (20%) patients. There are differences in the proportion of incident FNHTR in both groups although not statistically significant (P = 0.04). Every patient has different risk factors on parity, history of transfusion, history of FNHTR and the long of platelet storege. Conclusion. Medications pretransfusion acetaminophen 650 mg and diphenhydramine 25 mg reduced the incidence of FNHTR compared to placebo in the first platelet recipients in malignancy
first_indexed 2024-03-13T19:14:25Z
format Thesis
id oai:generic.eprints.org:39022
institution Universiti Gadjah Mada
last_indexed 2024-03-13T19:14:25Z
publishDate 2011
publisher [Yogyakarta] : Universitas Gadjah Mada
record_format dspace
spelling oai:generic.eprints.org:390222014-08-20T02:53:12Z https://repository.ugm.ac.id/39022/ PARACETAMOL DAN DIFENHIDRAMIN SEBAGAI MEDIKASI PRETRANFUSI KEJADIAN FEBRILE NON-HAEMOLYTIC REACTION TRANSFUSION RESIPIEN TROMBOSIT , Pudya Lestari Arhsanti , dr. Johan Kurnianda,. Sp. PD.KHOM. ETD Background. Blood transfusion can save lives, patients get the benefit but also the risk of transfusion-related. Febrile non-haemolytic tranfusion reaction (FNHTR) most frequently found and have similar symptoms of other transfusion reactions, causing delays in transfusion and decrease the quality of life. Platelet recipients have a higher incidence risk FNHTR than recipients of other blood products. Medications pretransfusion acetaminophen and diphenhydramine reduce the incidence FNHTR. Methods. The study was conducted from May to November 2010 Penyakit Dalam Wards, Dr. Sardjito Hospital, Yogyakarta using the method of double-blind randomized controlled trial. Inclusion criteria were first recipient of random donor non leucodepleted platelets in thrombocytopenia malignant patients and willing to participate. Exclusion criteria were fever is when will transfusions or in 2x24 hours, allergies of acetaminophen and diphenhydramine, acetaminophen and diphenhydramine consumption in the last 6 hours, the consumption of continuous corticosteroids, history of transfusion reactions and critical conditions/sepsis. Assessment of the incidence FNHTR than 15 minutes before transfusion to 4 hours after transfusion. Medication group will receive a capsule containing 650 mg acetaminophen and 25 mg diphenhydramine dissolved in 5 ml 0.9% NaCl intravenously. The control group received a placebo. Drugs are given 30 minutes before the first transfusion bag. Data were analyzed using Chi-square test and p <0.05 was considered statistically significant. Results. Thirty-two patients met the criteria, 15 patients (46.87%), medication group and 17 (53.13%) patients of control group. Eleven (31.43%) patients had FNHTR, 8 (47.06%) patients of control group and 3 (20%) patients. There are differences in the proportion of incident FNHTR in both groups although not statistically significant (P = 0.04). Every patient has different risk factors on parity, history of transfusion, history of FNHTR and the long of platelet storege. Conclusion. Medications pretransfusion acetaminophen 650 mg and diphenhydramine 25 mg reduced the incidence of FNHTR compared to placebo in the first platelet recipients in malignancy [Yogyakarta] : Universitas Gadjah Mada 2011 Thesis NonPeerReviewed , Pudya Lestari Arhsanti and , dr. Johan Kurnianda,. Sp. PD.KHOM. (2011) PARACETAMOL DAN DIFENHIDRAMIN SEBAGAI MEDIKASI PRETRANFUSI KEJADIAN FEBRILE NON-HAEMOLYTIC REACTION TRANSFUSION RESIPIEN TROMBOSIT. UNSPECIFIED thesis, UNSPECIFIED. http://etd.ugm.ac.id/index.php?mod=penelitian_detail&sub=PenelitianDetail&act=view&typ=html&buku_id=50168
spellingShingle ETD
, Pudya Lestari Arhsanti
, dr. Johan Kurnianda,. Sp. PD.KHOM.
PARACETAMOL DAN DIFENHIDRAMIN SEBAGAI MEDIKASI PRETRANFUSI KEJADIAN FEBRILE NON-HAEMOLYTIC REACTION TRANSFUSION RESIPIEN TROMBOSIT
title PARACETAMOL DAN DIFENHIDRAMIN SEBAGAI MEDIKASI PRETRANFUSI KEJADIAN FEBRILE NON-HAEMOLYTIC REACTION TRANSFUSION RESIPIEN TROMBOSIT
title_full PARACETAMOL DAN DIFENHIDRAMIN SEBAGAI MEDIKASI PRETRANFUSI KEJADIAN FEBRILE NON-HAEMOLYTIC REACTION TRANSFUSION RESIPIEN TROMBOSIT
title_fullStr PARACETAMOL DAN DIFENHIDRAMIN SEBAGAI MEDIKASI PRETRANFUSI KEJADIAN FEBRILE NON-HAEMOLYTIC REACTION TRANSFUSION RESIPIEN TROMBOSIT
title_full_unstemmed PARACETAMOL DAN DIFENHIDRAMIN SEBAGAI MEDIKASI PRETRANFUSI KEJADIAN FEBRILE NON-HAEMOLYTIC REACTION TRANSFUSION RESIPIEN TROMBOSIT
title_short PARACETAMOL DAN DIFENHIDRAMIN SEBAGAI MEDIKASI PRETRANFUSI KEJADIAN FEBRILE NON-HAEMOLYTIC REACTION TRANSFUSION RESIPIEN TROMBOSIT
title_sort paracetamol dan difenhidramin sebagai medikasi pretranfusi kejadian febrile non haemolytic reaction transfusion resipien trombosit
topic ETD
work_keys_str_mv AT pudyalestariarhsanti paracetamoldandifenhidraminsebagaimedikasipretranfusikejadianfebrilenonhaemolyticreactiontransfusionresipientrombosit
AT drjohankurniandasppdkhom paracetamoldandifenhidraminsebagaimedikasipretranfusikejadianfebrilenonhaemolyticreactiontransfusionresipientrombosit